Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocular Therapeutix, Inc. - Common Stock
(NQ:
OCUL
)
12.13
+0.03 (+0.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocular Therapeutix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
↗
June 20, 2024
Via
Benzinga
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
↗
June 20, 2024
Via
Benzinga
Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
↗
June 20, 2024
Via
Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 14, 2024
Via
Benzinga
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
↗
June 14, 2024
Via
Benzinga
Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings)
↗
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 28, 2024
Via
Benzinga
OCUL Stock Earnings: Ocular Therapeutix Misses EPS, Misses Revenue for Q1 2024
↗
May 07, 2024
OCUL stock results show that Ocular Therapeutix missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 06, 2024
Via
Benzinga
The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
↗
April 16, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Ocular Therapeutix
↗
March 13, 2024
Via
Benzinga
Ocular Therapeutix: Q4 Earnings Insights
↗
March 11, 2024
Via
Benzinga
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
May 06, 2024
Via
Benzinga
2 Small-Cap Growth Stocks With Room To Run
↗
April 24, 2024
These two small-cap growth stocks could be ready to run.
Via
The Motley Fool
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
April 19, 2024
Via
Benzinga
Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
↗
April 18, 2024
Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy. Significant DRSS improvement with no worsening observed. Positive Phase 2 data...
Via
Benzinga
Earnings Outlook For Ocular Therapeutix
↗
March 08, 2024
Via
Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
April 18, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
↗
April 16, 2024
Investors can find some of the hottest, most explosive opportunities in these three top biotech stocks to buy now.
Via
InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
↗
April 15, 2024
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Via
InvestorPlace
Million-Dollar Bets: 3 Under-$15 Stocks With Massive Potential
↗
April 01, 2024
Here are three under-$15 stocks with massive potential based on their strategic moves in the pharmaceuticals and banking industries.
Via
InvestorPlace
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
March 12, 2024
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Via
Benzinga
These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results
↗
March 12, 2024
Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.
Via
Benzinga
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
↗
March 12, 2024
Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis
Via
Benzinga
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
March 12, 2024
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
March 11, 2024
Via
Benzinga
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
↗
March 11, 2024
Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset...
Via
Benzinga
Earnings Scheduled For March 11, 2024
↗
March 11, 2024
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
Via
Benzinga
$7M Bet On Ocular Therapeutix? Check Out These 3 Stocks Insiders Are Buying
↗
February 28, 2024
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
Piper Sandler Maintains Overweight Rating for Ocular Therapeutix: Here's What You Need To Know
↗
February 26, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today